Singapore: Health Sciences Authority removes over 4,600 listings and seized more than 60,000 illegal health products as part of one-week international operation

In brief

In October 2023, the Health Sciences Authority (HSA) participated in a one-week INTERPOL-led, internet-based operation involving 89 member countries targeting the sale of illegal health products.

The HSA announced that it removed over 4,600 listings of illegal health products from local e-commerce and social media platforms and seized more than 60,000 units of illegal health products at the Singapore Customs during a week of intensified surveillance from 3 to 10 October 2023.


Contents

Key takeaways

  • Sellers and suppliers of health products should note that anyone who supplies in Singapore prescription medicines and medical devices, and/or health products that are adulterated, counterfeit or tampered with may face a fine of up to SGD 100,000 and/or imprisonment for up to three years.

In depth

On 31 October 2023, the HSA announced that 4,681 product listings of illegal health products were removed from e-commerce and social media platforms, and 60,372 units of illegal health products were seized during a one-week intensified enforcement action as part of Operation Pangea.

The removed product listings were mainly lifestyle health products, such as sexual enhancement or male vitality products, aesthetic enhancement products (dermal fillers, Botulinum toxin, sutures and placenta injectables), contraceptives, topical creams or ointments for skin allergy, and weight loss products. The seized products consisted of various illegal and adulterated health products, such as sexual enhancement products, sedatives, herbal supplements and pain management products. 

The HSA has advised members of the public to avoid buying prescription-only medicines (such as erectile dysfunction medicines, weight loss medicines and DIY aesthetic beauty injectable kits) and be wary of purchasing health products (such as health supplements and cosmetic products) online. Additionally, extra caution should be exercised with regard to health products that promise quick and miraculous results or carry exaggerated claims (such as "100% safe"; "no side effects"; "quick effects"; or "scientifically proven"). These are products that may be adulterated with potent medicinal ingredients or prescription-only products that should be administered only by qualified medical practitioners. Given that they have not been evaluated and/or approved by the HSA, there is no assurance of their safety, quality and efficacy. If used or administered incorrectly, serious adverse reactions may ensue.

Therefore, the HSA recommends that health products only be purchased online from reputable retailers' websites or those with an established retail presence in Singapore. 

Sellers and suppliers are also reminded not to sell prescription medicines and medical devices on e-commerce platforms, or health products that are adulterated or bear misleading claims.

The full HSA announcement may be found here.

 

* * * * *

LOGO_Wong&Leow_Singapore

© 2023 Baker & McKenzie.Wong & Leow. All rights reserved. Baker & McKenzie.Wong & Leow is incorporated with limited liability and is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a "principal" means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an "office" means an office of any such law firm. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.

Contact Information

Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.